Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines

Jae Gahb Park, Jerry M. Collins, Adi F. Gazdar, Carmen J. Allegra, Seth M. Steinberg, Raymond F. Greene, Barnett S. Kramer

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Reduced folates have been shown to increase the cytotoxicity of 5-fluorouracil (5-FU) by stabilizing the 5-fluoro-2′-deoxyuridine-5′-monophosphate-thymidylate synthase complex, thus increasing the block in the DNA synthetic pathway. Using an in vitro colorimetric [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] cytotoxicity assay, we tested the effects of 5-FU and 5-fluoro-2′-deoxyuridine (FdUrd) with and without leucovorin (LV) on a panel of 11 human colorectal carcinoma cell lines. The effect of LV on 5-FU and FdUrd was quantitatively similar. A clinically achievable level of LV (20 μM) increased the cytotoxicity in all three replicate experiments in 10 of the 11 cell lines (P < .05, binomial test). LV alone at a concentration of 20 μM had no effect on cell survival. In three cell lines, 50% inhibition of growth occurred at a clinically achievable area under the curve of 5-FU alone. With the addition of LV, one additional cell line showed 50% growth inhibition at a clinically achievable level of 5-EU. Hence large clinical trials may be necessary to detect a significant improvement in survival as a result of adding LV to the fluorinated pyrimidines. [J Nail Cancer Inst 188;80:1560-1564]

Original languageEnglish (US)
Pages (from-to)1560-1564
Number of pages5
JournalJournal of the National Cancer Institute
Volume80
Issue number19
DOIs
StatePublished - Jul 7 1988

Fingerprint

Cytotoxicity
Leucovorin
Colorectal Neoplasms
Enhancement
Cells
Cell Line
Fluorouracil
Line
Cell
Fluorodeoxyuridylate
Nails
Thymidylate Synthase
Pyrimidines
Clinical Trials
Growth
Assays
Pathway
Cancer
Folic Acid
DNA

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Radiology Nuclear Medicine and imaging
  • Oncology
  • Cancer Research

Cite this

Park, J. G., Collins, J. M., Gazdar, A. F., Allegra, C. J., Steinberg, S. M., Greene, R. F., & Kramer, B. S. (1988). Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. Journal of the National Cancer Institute, 80(19), 1560-1564. https://doi.org/10.1093/jnci/80.19.1560

Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. / Park, Jae Gahb; Collins, Jerry M.; Gazdar, Adi F.; Allegra, Carmen J.; Steinberg, Seth M.; Greene, Raymond F.; Kramer, Barnett S.

In: Journal of the National Cancer Institute, Vol. 80, No. 19, 07.07.1988, p. 1560-1564.

Research output: Contribution to journalArticle

Park, JG, Collins, JM, Gazdar, AF, Allegra, CJ, Steinberg, SM, Greene, RF & Kramer, BS 1988, 'Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines', Journal of the National Cancer Institute, vol. 80, no. 19, pp. 1560-1564. https://doi.org/10.1093/jnci/80.19.1560
Park, Jae Gahb ; Collins, Jerry M. ; Gazdar, Adi F. ; Allegra, Carmen J. ; Steinberg, Seth M. ; Greene, Raymond F. ; Kramer, Barnett S. / Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. In: Journal of the National Cancer Institute. 1988 ; Vol. 80, No. 19. pp. 1560-1564.
@article{369b04a6c1b54734bdf650387a1175e7,
title = "Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines",
abstract = "Reduced folates have been shown to increase the cytotoxicity of 5-fluorouracil (5-FU) by stabilizing the 5-fluoro-2′-deoxyuridine-5′-monophosphate-thymidylate synthase complex, thus increasing the block in the DNA synthetic pathway. Using an in vitro colorimetric [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] cytotoxicity assay, we tested the effects of 5-FU and 5-fluoro-2′-deoxyuridine (FdUrd) with and without leucovorin (LV) on a panel of 11 human colorectal carcinoma cell lines. The effect of LV on 5-FU and FdUrd was quantitatively similar. A clinically achievable level of LV (20 μM) increased the cytotoxicity in all three replicate experiments in 10 of the 11 cell lines (P < .05, binomial test). LV alone at a concentration of 20 μM had no effect on cell survival. In three cell lines, 50{\%} inhibition of growth occurred at a clinically achievable area under the curve of 5-FU alone. With the addition of LV, one additional cell line showed 50{\%} growth inhibition at a clinically achievable level of 5-EU. Hence large clinical trials may be necessary to detect a significant improvement in survival as a result of adding LV to the fluorinated pyrimidines. [J Nail Cancer Inst 188;80:1560-1564]",
author = "Park, {Jae Gahb} and Collins, {Jerry M.} and Gazdar, {Adi F.} and Allegra, {Carmen J.} and Steinberg, {Seth M.} and Greene, {Raymond F.} and Kramer, {Barnett S.}",
year = "1988",
month = "7",
day = "7",
doi = "10.1093/jnci/80.19.1560",
language = "English (US)",
volume = "80",
pages = "1560--1564",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "19",

}

TY - JOUR

T1 - Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines

AU - Park, Jae Gahb

AU - Collins, Jerry M.

AU - Gazdar, Adi F.

AU - Allegra, Carmen J.

AU - Steinberg, Seth M.

AU - Greene, Raymond F.

AU - Kramer, Barnett S.

PY - 1988/7/7

Y1 - 1988/7/7

N2 - Reduced folates have been shown to increase the cytotoxicity of 5-fluorouracil (5-FU) by stabilizing the 5-fluoro-2′-deoxyuridine-5′-monophosphate-thymidylate synthase complex, thus increasing the block in the DNA synthetic pathway. Using an in vitro colorimetric [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] cytotoxicity assay, we tested the effects of 5-FU and 5-fluoro-2′-deoxyuridine (FdUrd) with and without leucovorin (LV) on a panel of 11 human colorectal carcinoma cell lines. The effect of LV on 5-FU and FdUrd was quantitatively similar. A clinically achievable level of LV (20 μM) increased the cytotoxicity in all three replicate experiments in 10 of the 11 cell lines (P < .05, binomial test). LV alone at a concentration of 20 μM had no effect on cell survival. In three cell lines, 50% inhibition of growth occurred at a clinically achievable area under the curve of 5-FU alone. With the addition of LV, one additional cell line showed 50% growth inhibition at a clinically achievable level of 5-EU. Hence large clinical trials may be necessary to detect a significant improvement in survival as a result of adding LV to the fluorinated pyrimidines. [J Nail Cancer Inst 188;80:1560-1564]

AB - Reduced folates have been shown to increase the cytotoxicity of 5-fluorouracil (5-FU) by stabilizing the 5-fluoro-2′-deoxyuridine-5′-monophosphate-thymidylate synthase complex, thus increasing the block in the DNA synthetic pathway. Using an in vitro colorimetric [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] cytotoxicity assay, we tested the effects of 5-FU and 5-fluoro-2′-deoxyuridine (FdUrd) with and without leucovorin (LV) on a panel of 11 human colorectal carcinoma cell lines. The effect of LV on 5-FU and FdUrd was quantitatively similar. A clinically achievable level of LV (20 μM) increased the cytotoxicity in all three replicate experiments in 10 of the 11 cell lines (P < .05, binomial test). LV alone at a concentration of 20 μM had no effect on cell survival. In three cell lines, 50% inhibition of growth occurred at a clinically achievable area under the curve of 5-FU alone. With the addition of LV, one additional cell line showed 50% growth inhibition at a clinically achievable level of 5-EU. Hence large clinical trials may be necessary to detect a significant improvement in survival as a result of adding LV to the fluorinated pyrimidines. [J Nail Cancer Inst 188;80:1560-1564]

UR - http://www.scopus.com/inward/record.url?scp=0024227210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024227210&partnerID=8YFLogxK

U2 - 10.1093/jnci/80.19.1560

DO - 10.1093/jnci/80.19.1560

M3 - Article

C2 - 2973527

AN - SCOPUS:0024227210

VL - 80

SP - 1560

EP - 1564

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 19

ER -